BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Three new companies spring to life from boron research at RTP-based Boragen
Research Triangle Park-based Boragen to be split into three different companies, one focused on crop protection, one on animal health, and the other on human health.
